(Cost-)effectiveness of focal therapy versus radical therapy (standard of care) in the treatment of men with intermediate-risk prostate cancer: study protocol for the ENFORCE focal randomised controlled trial.
- DOI
- 10.1136/bmjopen-2026-117276
- Published
- 2026 Jul 8
- Container
- BMJ open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/bmjopen-2026-117276,
title = {(Cost-)effectiveness of focal therapy versus radical therapy (standard of care) in the treatment of men with intermediate-risk prostate cancer: study protocol for the ENFORCE focal randomised controlled trial.},
author = {Te Molder LPW and Sedelaar JPM and Bomers JGR and Boomsma MF and de Haan TD and van Melick HHE and Meijerink MR and Beerlage HP and van Aubel O and Collette ER and Grutters JPC and Hannink G and Rovers MM and Fütterer JJ and ENFORCE Focal consortium},
year = {2026},
journal = {BMJ open},
doi = {10.1136/bmjopen-2026-117276},
url = {https://doi.org/10.1136/bmjopen-2026-117276}
}RIS
TY - JOUR TI - (Cost-)effectiveness of focal therapy versus radical therapy (standard of care) in the treatment of men with intermediate-risk prostate cancer: study protocol for the ENFORCE focal randomised controlled trial. AU - Te Molder LPW AU - Sedelaar JPM AU - Bomers JGR AU - Boomsma MF AU - de Haan TD AU - van Melick HHE AU - Meijerink MR AU - Beerlage HP AU - van Aubel O AU - Collette ER AU - Grutters JPC AU - Hannink G AU - Rovers MM AU - Fütterer JJ AU - ENFORCE Focal consortium PY - 2026 JO - BMJ open DO - 10.1136/bmjopen-2026-117276 UR - https://doi.org/10.1136/bmjopen-2026-117276 ER -
APA
LPW, T. M., JPM, S., JGR, B., MF, B., TD, D. H., HHE, V. M., MR, M., HP, B., O, V. A., ER, C., JPC, G., G, H., MM, R., JJ, F., & consortium, E. F. (2026). (Cost-)effectiveness of focal therapy versus radical therapy (standard of care) in the treatment of men with intermediate-risk prostate cancer: study protocol for the ENFORCE focal randomised controlled trial.. BMJ open. https://doi.org/10.1136/bmjopen-2026-117276
Source records
- pubmed · retrieved 2026-09-25T12:00:05.383Z